It was a low-key week for the biotech sector with no major updates. Regulatory and pipeline updates from a few players were in focus. Vertex and CRISPR collaborated in 2015 to focus on the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback